{
"id":"mk19_b_cv_s6",
"subspecialtyId":"cv",
"title":"Valvular Heart Disease",
"jsonContent":{
"type":"section",
"id":"mk19_b_cv_s6",
"title":{
"__html":"Valvular Heart Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"959b4e",
"children":[
"Valvular Heart Disease"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_cv_s6_1",
"title":{
"__html":"General Principles"
},
"titleNode":{
"type":"section-title",
"hlId":"1a0eb4",
"children":[
"General Principles"
]
},
"children":[
{
"type":"p",
"hlId":"6b6766",
"children":[
"Valvular heart disease (VHD) involves cardiac dysfunction due to structural or functional valve abnormalities resulting from failure of the valves to either competently close (regurgitation) or effectively open (stenosis). VHD affects approximately 20 million persons in the United States. Although there are congenital forms, VHD is largely age dependent, with a prevalence of 3% to 6% in persons aged 65 years or older."
]
},
{
"type":"p",
"hlId":"2a55ef",
"children":[
"Many heart valve lesions progress slowly, causing patients to limit their activity unconsciously in response; therefore, a careful history and detailed physical examination are essential. Exertional dyspnea is the most common symptom. Depending on the lesion and severity, other symptoms include angina, syncope, palpitations, lower extremity edema, and increasing girth (ascites). Typical physical examination findings for valvular and other cardiac lesions are described in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t21",
"wrapId":"1",
"children":[
"Table 21"
]
}
]
},
" (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_b_cv_v02",
"wrapId":"1",
"children":[
"Video 2"
]
}
]
},
" demonstrates normal S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" splitting). Twelve-lead ECG, chest radiography, and transthoracic echocardiography (TTE) are the essential tests used to evaluate VHD."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_b_cv_t21",
"mk19_b_cv_v02"
]
},
{
"type":"p",
"hlId":"773201",
"children":[
"To facilitate the timing of monitoring and intervention, VHD is classified into four stages (A through D), which consider risk factors, presence of symptoms, lesion severity, ventricular response to the volume or pressure overload caused by the lesion, effect on the pulmonary or systemic circulation, and heart rhythm changes ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t22",
"wrapId":"2",
"children":[
"Table 22"
]
}
]
},
")"
]
},
". Surveillance intervals for echocardiographic evaluation based on disease severity are listed in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t23",
"wrapId":"2",
"children":[
"Table 23"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_b_cv_t22",
"mk19_b_cv_t23"
]
},
{
"type":"p",
"hlId":"dfa290",
"children":[
"Medical therapy, although often effective for symptom palliation, has not been shown to prevent VHD progression or improve long-term survival in patients with VHD. Surgery, however, can be a life-saving intervention in select patients, and surgical risk calculation is a key component of the patient evaluation. Risk calculation involves assessment of the patient's age, morbidities, frailty, and impediments specific to the procedure under consideration (e.g., previous chest irradiation for a sternotomy approach). Risk calculators derived from national databases can assist in estimating risk for morbidity and mortality for surgical valve procedures. One such calculator, the Society of Thoracic Surgeons Adult Cardiac Surgery Risk Calculator, is available at ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://riskcalc.sts.org/stswebriskcalc",
"target":"_blank"
},
"children":[
"http://riskcalc.sts.org/stswebriskcalc"
]
},
". Although risk calculators contain many data inputs, frailty and some other important patient and procedural characteristics are not factored into the calculations. Therefore, a comprehensive approach is required for determining patient surgical risk and candidacy. Frailty, which is variably defined as a geriatric syndrome of decline in several physiologic systems and processes, portends an increased risk for mortality in patients undergoing surgery and can be measured preoperatively (see MKSAP 19 ",
{
"type":"cross-reference",
"target":"mk19_a_gm_s10_2",
"children":[
"General Internal Medicine 1"
]
},
")."
]
},
{
"type":"p",
"hlId":"de951e",
"children":[
"For all patients in whom surgical or interventional therapy is being considered, a multidisciplinary approach with a heart team consisting of a cardiologist, a surgeon, and an interventional cardiologist is recommended. Evaluations in centers with specialized expertise in VHD (e.g., a Heart Valve Center of Excellence) is also advised for patients in whom intervention is being considered when there are no symptoms, multiple or complex morbidities are present, or surgical valve repair is favored over valve replacement."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"48361a",
"children":[
"Many heart valve lesions progress slowly, causing patients to limit their activity unconsciously in response; therefore, a careful history and detailed physical examination are essential."
]
},
{
"type":"keypoint",
"hlId":"1d33a8",
"children":[
"Medical therapy, although often effective for symptom palliation, has not been shown to prevent disease progression or improve long-term survival in patients with valvular heart disease."
]
},
{
"type":"keypoint",
"hlId":"e1b20e",
"children":[
"For all patients with valvular heart disease in whom surgical or interventional therapy is being considered, a multidisciplinary approach with a heart team consisting of a cardiologist, a surgeon, and an interventional cardiologist is recommended."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_2",
"title":{
"__html":"Aortic Stenosis"
},
"titleNode":{
"type":"section-title",
"hlId":"5be17a",
"children":[
"Aortic Stenosis"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_cv_s6_2_1",
"title":{
"__html":"Clinical Presentation and Evaluation"
},
"titleNode":{
"type":"section-title",
"hlId":"727f2a",
"children":[
"Clinical Presentation and Evaluation"
]
},
"children":[
{
"type":"p",
"hlId":"825c19",
"children":[
"Aortic stenosis may be congenital, as in persons with a bicuspid aortic valve, or acquired. The most common cause is degeneration of the valve that occurs with aging ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_cv_f30",
"wrapId":"3",
"children":[
"Figure 30"
]
}
]
},
")"
]
},
"; severe lesions occur in approximately 3% of persons aged 65 years or older. Other acquired causes include rheumatic disease and chest irradiation. Although rheumatic disease of the mitral valve frequently occurs in isolation, rheumatic aortic valve disease almost never occurs without mitral valve involvement. Chest irradiation (e.g., mantle therapy for Hodgkin lymphoma) commonly results in a combination of stenosis and regurgitation."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_b_cv_f30"
]
},
{
"type":"p",
"hlId":"0cfbb7",
"children":[
"Aortic stenosis causes chronic pressure overload of the left ventricle (LV), leading to concentric LV hypertrophy and myocardial interstitial fibrosis. Diastolic dysfunction follows, with eventual systolic heart failure and pulmonary congestion. The disease typically progresses with a decrease in the aortic valve area of approximately 0.12 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
" per year, but the rate depends on patient age, underlying severity of the stenosis, and comorbid conditions, such as kidney failure and hypertension. Exertional dyspnea, syncope, and angina are the most common symptoms; however, symptoms may not appear until stenosis is severe. Among asymptomatic patients with severe aortic stenosis, 75% will die or develop symptoms within 5 years. Once symptoms occur, life expectancy is generally only 1 to 2 years. Thus, serial evaluation every 6 to 12 months is recommended for patients with severe disease (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t23",
"wrapId":"4",
"children":[
"Table 23"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_b_cv_t23"
]
},
{
"type":"p",
"hlId":"67e1d7",
"children":[
"The characteristic clinical findings of severe aortic stenosis include a late-peaking systolic murmur (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_b_cv_v03",
"wrapId":"5",
"children":[
"Video 3"
]
}
]
},
"), a diminished or absent aortic component of the S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
", and a delay in the carotid upstroke (pulsus tardus) that may be accompanied by a decreased pulse amplitude due to low cardiac output (pulsus parvus). Clinical findings suggestive of severe aortic stenosis should be promptly evaluated (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t21",
"wrapId":"5",
"children":[
"Table 21"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_b_cv_v03",
"mk19_b_cv_t21"
]
},
{
"type":"p",
"hlId":"52eda8",
"children":[
"The primary imaging modality for evaluation of aortic stenosis is TTE ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_cv_f31",
"wrapId":"6",
"children":[
"Figure 31"
]
}
]
},
")"
]
},
". Echocardiography can determine the cause of stenosis, stenosis severity (with gradient and valve area assessment), LV function and wall thickness, right ventricular (RV) function, pulmonary artery pressure, and the presence or absence of other valve pathology. In some patients, echocardiography may underestimate the severity of aortic stenosis. Further evaluation with cardiac catheterization, during which cardiac output and the aortic pressure gradient can be measured, is required when there are discrepancies between the clinical and echocardiographic findings in symptomatic patients being considered for intervention. Exercise stress testing is useful in asymptomatic patients with severe aortic stenosis to confirm asymptomatic status, but it should be performed under cardiologist supervision. Exercise stress testing is contraindicated in symptomatic severe aortic stenosis."
]
},
{
"type":"inline-wrap",
"wrapId":"6",
"contentIds":[
"mk19_b_cv_f31"
]
},
{
"type":"p",
"hlId":"ddf6bf",
"children":[
"Severe aortic stenosis is typically defined by a small valve area (≤1.0 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
"), high peak velocity (>4 m/s), and/or high mean gradient (>40 mm Hg). There are two patient subsets in which severe aortic stenosis may be present with a small valve area and either low velocity or low gradient—(1) patients with severe LV dysfunction and low cardiac output (low-flow, low-gradient aortic stenosis) and (2) patients with preserved LV function and paradoxical low-flow, low-gradient aortic stenosis. In the former group, dobutamine echocardiography or dobutamine cardiac catheterization is needed to distinguish true aortic stenosis from pseudostenosis. In pseudostenosis, dobutamine increases cardiac output and the opening forces on the aortic valve, causing the valve area to increase out of the severe range. With low-flow, low-gradient aortic stenosis, the calculated valve area remains in the severe range with dobutamine administration, and the aortic valve gradient and velocity increase with increased stroke volume. Patients with paradoxical low-flow, low-gradient aortic stenosis have low stroke volume (<35 mL/m",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
") resulting from a combination of small LV size and high aortic impedance to flow (e.g., hypertension) or other causes of low cardiac output (e.g., atrial fibrillation, pulmonary hypertension). Determination of lesion severity in paradoxical aortic stenosis requires consideration of the hemodynamics, valve morphology (e.g., degree of calcification), presence of LV hypertrophy, and clinical presentation of the patient. In patients with suspected low-flow, low-gradient severe aortic stenosis with normal or reduced left ventricular ejection fraction, measurement of aortic valve calcium score by CT is reasonable to further define severity. In patients with either low-flow, low-gradient severe aortic stenosis with reduced LV function or paradoxical low-flow, low-gradient severe aortic stenosis, observational studies have shown improved survival with aortic valve replacement compared with medical therapy."
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_2_2",
"title":{
"__html":"Management"
},
"titleNode":{
"type":"section-title",
"hlId":"fe4dbc",
"children":[
"Management"
]
},
"children":[
{
"type":"p",
"hlId":"d9f22a",
"children":[
"Aortic valve replacement is a life-prolonging procedure in patients with severe aortic stenosis. The indications for aortic valve replacement in severe aortic stenosis are the presence of symptoms (e.g., dyspnea, angina, presyncope, syncope, or heart failure), LV systolic dysfunction (ejection fraction <50%) in an asymptomatic patient, or a concomitant cardiac surgical procedure for other indications (e.g., coronary artery bypass grafting or ascending aorta surgery). Aortic valve replacement is reasonable in asymptomatic patients with very severe aortic stenosis and low surgical risk and asymptomatic patients with abnormal results on supervised exercise testing, such as poor exercise tolerance, abnormal ECG changes, or hypotension during testing."
]
},
{
"type":"p",
"hlId":"cc0ac0",
"children":[
"Aortic valve replacement can be performed with open cardiac surgery (surgical aortic valve replacement [SAVR]) or via transcatheter approach (transcatheter aortic valve implantation [TAVI]) ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_cv_f32",
"wrapId":"7",
"children":[
"Figure 32"
]
}
]
},
")"
]
},
". SAVR and TAVI have similar procedural and long-term survival rates, with expected operative mortality rates of 1% to 3%. The choice between surgical and transcatheter interventions is based on the presence of symptoms and the patient's surgical risk, as determined through comprehensive multidisciplinary assessment. TAVI is recommended over SAVR for symptomatic patients with severe aortic stenosis who are older than 80 years or for younger patients with a life expectancy less than 10 years. TAVI is also recommended over SAVR for symptomatic patients of any age with severe aortic stenosis and a high or prohibitive surgical risk if predicted postprocedure survival is more than 12 months with an acceptable quality of life. For symptomatic patients who are aged 65 to 80 years, either SAVR or TAVI is appropriate following shared decision making. Neither SAVR nor TAVI is indicated in patients with limited expectation of survival due to comorbid conditions."
]
},
{
"type":"inline-wrap",
"wrapId":"7",
"contentIds":[
"mk19_b_cv_f32"
]
},
{
"type":"p",
"hlId":"568519",
"children":[
"Although the pathophysiology of aortic stenosis is known to be inflammatory, randomized trials have shown medical therapy, specifically statins, to be ineffective in slowing disease progression. For patients with coexistent hypertension or heart failure, guideline-directed medical therapy is recommended. Vasodilators should be used with caution in patients with aortic stenosis and heart failure symptoms. In select cases, balloon valvuloplasty may be used to bridge unstable patients to therapy with TAVI or SAVR."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"7c2e17",
"children":[
"The characteristic clinical findings of severe aortic stenosis include a late-peaking systolic murmur, a diminished or absent aortic component of the S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
", and a weak and delayed carotid upstroke."
]
},
{
"type":"keypoint",
"hlId":"c88244",
"children":[
"Echocardiography is accurate for defining the severity of aortic stenosis in most patients; when there is a discrepancy between the clinical and echocardiographic findings, cardiac catheterization should be considered in patients who are candidates for intervention."
]
},
{
"type":"keypoint",
"hlId":"b01e57",
"children":[
"Patients with low-flow, low-gradient aortic stenosis have a small valve area but low velocity and/or low gradient due to low stroke volume; dobutamine echocardiography or cardiac catheterization can be used to distinguish pseudo-severe aortic stenosis from true severe aortic stenosis."
]
},
{
"type":"keypoint",
"hlId":"eb9cc2",
"children":[
"Aortic valve replacement prolongs life in patients with symptomatic severe aortic stenosis; the patient's surgical risk determines whether valve replacement is performed using open surgery or a transcatheter approach."
]
},
{
"type":"keypoint",
"hlId":"2269e4",
"children":[
"Transcatheter aortic valve implantation is indicated for symptomatic patients with trileaflet aortic stenosis at any level of surgical risk who do not have concomitant severe aortic regurgitation."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_3",
"title":{
"__html":"Aortic Regurgitation"
},
"titleNode":{
"type":"section-title",
"hlId":"035ea8",
"children":[
"Aortic Regurgitation"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_cv_s6_3_1",
"title":{
"__html":"Clinical Presentation and Evaluation"
},
"titleNode":{
"type":"section-title",
"hlId":"727f2a",
"children":[
"Clinical Presentation and Evaluation"
]
},
"children":[
{
"type":"p",
"hlId":"5c6a72",
"children":[
"Aortic regurgitation, manifesting acutely or chronically, arises from aortic root pathology or intrinsic valve disease. Causes of chronic aortic regurgitation include ascending aortic dilatation and valve abnormalities due to bicuspid disease, calcific degeneration, rheumatic involvement, or chest irradiation. Acute aortic regurgitation may be caused by endocarditis, blunt chest trauma, iatrogenic damage (e.g., complications of balloon aortic valvuloplasty), or aortic dissection."
]
},
{
"type":"p",
"hlId":"bfc290",
"children":[
"In chronic aortic regurgitation, volume overload causes progressive LV dilatation and eccentric hypertrophy. Chronic aortic regurgitation may be tolerated for many years but may eventually lead to symptoms, including shortness of breath, fatigue, or angina. Clinical findings result from the large stroke volume and LV dilatation and include bounding peripheral pulses, displacement of the LV apex, and a diastolic decrescendo murmur (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_b_cv_v04",
"wrapId":"8",
"children":[
"Video 4"
]
}
]
},
") heard either along the right sternal border (suggesting root pathology) or left sternal border (suggesting valve pathology) (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t21",
"wrapId":"8",
"children":[
"Table 21"
]
}
]
},
")"
]
},
". The large forward stroke volume also can cause an early-peaking systolic ejection murmur."
]
},
{
"type":"inline-wrap",
"wrapId":"8",
"contentIds":[
"mk19_b_cv_v04",
"mk19_b_cv_t21"
]
},
{
"type":"p",
"hlId":"5936dd",
"children":[
"In acute regurgitation, the abrupt onset of volume overload may cause acute heart failure or even cardiogenic shock. Bounding pulses may not be present because stroke volume has not markedly increased, and murmurs may be softer or shorter in duration because of the rapid equalization of pressures between the aorta and LV."
]
},
{
"type":"p",
"hlId":"75876b",
"children":[
"TTE is indicated for evaluation of aortic regurgitation and LV function. In patients with moderate or severe aortic regurgitation and suboptimal TTE images or a discrepancy between clinical and TTE findings, transesophageal echocardiography (TEE), cardiac magnetic resonance (CMR) imaging, or cardiac catheterization is indicated. When endocarditis is suspected, TTE is the initial imaging test in most patients. TEE following TTE is recommended for patients with suboptimal TTE results or with high initial risk. CT angiography is indicated in patients with acute AR and aortic dissection because it is highly accurate and usually rapidly available."
]
},
{
"type":"p",
"hlId":"da55bc",
"children":[
"Criteria for severe aortic regurgitation include a jet width that occupies 65% or more of the LV outflow tract, vena contracta (the width of the regurgitant jet at its most narrow portion) greater than 0.6 cm, holodiastolic flow in the descending aorta, regurgitation volume of 60 mL or more, and effective regurgitant orifice area of 0.3 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
" or greater. The LV typically is dilated in chronic aortic regurgitation. In patients suspected of having an aortic root abnormality, evaluation with CMR imaging, CT, or TEE is recommended. Surveillance is based on severity of regurgitation and other factors (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t23",
"wrapId":"9",
"children":[
"Table 23"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"9",
"contentIds":[
"mk19_b_cv_t23"
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_3_2",
"title":{
"__html":"Management"
},
"titleNode":{
"type":"section-title",
"hlId":"fe4dbc",
"children":[
"Management"
]
},
"children":[
{
"type":"p",
"hlId":"ad3b7c",
"children":[
"In chronic aortic regurgitation, surgery with traditional open aortic valve replacement is advised for patients with symptoms (typically, dyspnea or angina) or LV dysfunction (ejection fraction ≤55%) thought to be due to aortic regurgitation or for patients with severe aortic regurgitation who are undergoing other cardiac surgery. Surgical treatment of aortic regurgitation is reasonable in asymptomatic patients with severe AR, normal left ventricular function, and significant LV dilatation (end-systolic dimension >50 mm or indexed end-systolic dimension >25 mm/m",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
"). In patients with isolated severe aortic regurgitation who have indications for SAVR and are candidates for surgery, TAVI should not be performed."
]
},
{
"type":"p",
"hlId":"7f3f52",
"children":[
"Medical therapy, preferably with dihydropyridine calcium channel blockers, ACE inhibitors, or angiotensin receptor blockers (ARBs), is indicated in patients with chronic aortic regurgitation and concomitant hypertension. Therapy with ACE inhibitors or ARBs and β-blockers is reasonable in severe aortic regurgitation with symptoms or LV dysfunction when surgery is not an option."
]
},
{
"type":"p",
"hlId":"a50f3b",
"children":[
"Significant acute aortic regurgitation due to aortic dissection is a surgical emergency, requiring aortic dissection repair and aortic valve replacement or repair. For other acute causes, the indications for surgery depend on the regurgitation severity, presence of symptoms, and hemodynamic stability of the patient."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"ee9c8b",
"children":[
"Characteristic clinical findings of chronic aortic regurgitation include bounding peripheral pulses, displacement of the left ventricular apex, and a diastolic decrescendo murmur heard along the right or left sternal border."
]
},
{
"type":"keypoint",
"hlId":"aca94d",
"children":[
"In chronic aortic regurgitation, surgery with traditional open aortic valve replacement is advised for patients with symptoms or left ventricular dysfunction, or who have severe asymptomatic aortic regurgitation and are undergoing other cardiac surgery; in symptomatic patients who are not surgical candidates, medical therapy is appropriate."
]
},
{
"type":"keypoint",
"hlId":"2a3359",
"children":[
"Medical therapy with dihydropyridine calcium channel blockers, ACE inhibitors, or angiotensin receptor blockers is recommended for patients with chronic aortic regurgitation and concomitant hypertension."
]
},
{
"type":"keypoint",
"hlId":"92ff97",
"children":[
"Emergent surgery is indicated for patients with acute aortic regurgitation due to aortic dissection."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_4",
"title":{
"__html":"Bicuspid Aortic Valve Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"ffe65f",
"children":[
"Bicuspid Aortic Valve Disease"
]
},
"children":[
{
"type":"p",
"hlId":"86cecf",
"children":[
"Bicuspid aortic valve disease affects approximately 1% to 2% of the general population. Bicuspid morphology leads to abnormal shear forces and predisposes to early degeneration of the valve, resulting in stenosis in most patients (up to 75%) (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_cv_f30",
"wrapId":"10",
"children":[
"Figure 30"
]
}
]
},
")"
]
},
" and pure regurgitation in a small minority of patients (2%-10%). Patients with a bicuspid aortic valve typically present with an asymptomatic finding of a systolic ejection murmur in adolescence or young adulthood and gradually progress to severe disease in the fifth or sixth decade of life. More than one third of those older than 70 years with severe aortic stenosis have an underlying bicuspid valve."
]
},
{
"type":"inline-wrap",
"wrapId":"10",
"contentIds":[
"mk19_b_cv_f30"
]
},
{
"type":"p",
"hlId":"ed489d",
"children":[
"Bicuspid valvulopathy is often accompanied by aortic abnormalities, independent of the severity of aortic stenosis or regurgitation, and may be associated with aneurysm, dissection, or coarctation. Therefore, in patients with a bicuspid aortic valve, the ascending aorta and aortic arch should be examined for aortopathy with TTE. CMR angiography or CT angiography is indicated when echocardiographic assessment is suboptimal. Lifelong serial imaging is indicated if abnormalities are detected. The imaging modality and frequency depend on several factors, including the nature (stenosis, regurgitation, or aneurysm) and severity of the abnormality, age of the patient, family history, and candidacy for surgery. Importantly, bicuspid aortic valve is a heritable abnormality, and first-degree relatives of patients with a bicuspid aortic valve and aortopathy may be considered for screening with echocardiography."
]
},
{
"type":"p",
"hlId":"fec547",
"children":[
"Management of bicuspid aortic valve disease is determined by the predominant lesion type (stenosis or regurgitation) and its severity. In patients with a bicuspid valve undergoing surgery for severe aortic stenosis or regurgitation, surgical repair of the ascending aorta is reasonable when the aortic dimension is 4.5 cm or greater. In the absence of surgical indications for a stenotic or regurgitant aortic valve, surgical repair of the ascending aorta or aortic sinuses is recommended when the aortic dimension is greater than 5.5 cm and may be reasonable when the dimension is greater than 5.0 cm with an additional risk factor for dissection (e.g., family history, rate of progression ≥0.5 cm/year)."
]
},
{
"type":"p",
"hlId":"c94fdd",
"children":[
"No medical therapies slow aortic dilatation in patients with aortopathy and a bicuspid aortic valve. Blood pressure should be controlled in patients with concomitant hypertension."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"a49d43",
"children":[
"Bicuspid morphology predisposes to early degeneration of the aortic valve, resulting in stenosis in most patients and pure regurgitation in few patients."
]
},
{
"type":"keypoint",
"hlId":"f81781",
"children":[
"Patients with a bicuspid aortic valve typically present with an incidental systolic ejection murmur in adolescence or young adulthood and gradually progress to severe disease in the fifth or sixth decade of life."
]
},
{
"type":"keypoint",
"hlId":"db900b",
"children":[
"Management of bicuspid aortic valve disease follows the recommendations for the predominant valve lesion type (aortic stenosis or regurgitation) and its severity."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_5",
"title":{
"__html":"Mitral Stenosis"
},
"titleNode":{
"type":"section-title",
"hlId":"3c8aab",
"children":[
"Mitral Stenosis"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_cv_s6_5_1",
"title":{
"__html":"Clinical Presentation and Evaluation"
},
"titleNode":{
"type":"section-title",
"hlId":"727f2a",
"children":[
"Clinical Presentation and Evaluation"
]
},
"children":[
{
"type":"p",
"hlId":"6c93c4",
"children":[
"The leading cause of mitral stenosis is rheumatic heart disease, which is more common in women than in men (4:1 ratio). Although relatively rare in the United States, rheumatic heart disease is frequent in populations with limited access to treatment for streptococcal pharyngitis. Rheumatic heart disease results in fusion of the mitral commissures and, in more advanced forms, calcification of the valve and abnormalities in the subvalvular apparatus ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_cv_f33",
"wrapId":"11",
"children":[
"Figure 33"
]
}
]
},
")"
]
},
". Other causes of mitral stenosis are parachute mitral valve, chest irradiation, and severe mitral annular calcification. Mitral annular calcification is more common in the elderly and is associated with inflammatory disorders, peripheral artery disease, and chronic kidney disease."
]
},
{
"type":"inline-wrap",
"wrapId":"11",
"contentIds":[
"mk19_b_cv_f33"
]
},
{
"type":"p",
"hlId":"2074e3",
"children":[
"The natural history of mitral stenosis is characterized by slow progression over decades, with gradual left atrial (LA) enlargement and preservation of LV function. Symptoms may arise from low cardiac output (fatigue), pulmonary congestion (dyspnea), and pulmonary hypertension with right-sided heart failure (lower extremity edema). Pregnancy, with the resulting increased blood volume and cardiac output, may also precipitate symptoms. Symptoms are typically exertional because exercise shortens diastolic filling time and increases the transvalvular flow and diastolic mitral gradient, leading to worsening of LA hypertension. Patients also can present with systemic embolization, atrial fibrillation, or, in severe cases, hemoptysis. Heart failure is the cause of death in approximately 60% of patients with mitral stenosis, with thromboembolism causing most others."
]
},
{
"type":"p",
"hlId":"497bfb",
"children":[
"Clinical findings when the valve is pliable include a tapping LV impulse, a loud S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
", an increased pulmonic component of S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
", a diastolic opening snap, and a diastolic rumble or low-pitched murmur at the apex (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_b_cv_v05",
"wrapId":"12",
"children":[
"Video 5"
]
}
]
},
", see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t21",
"wrapId":"12",
"children":[
"Table 21"
]
}
]
},
")"
]
},
". Signs of pulmonary or systemic congestion may be present depending on lesion severity and the patient's volume status."
]
},
{
"type":"inline-wrap",
"wrapId":"12",
"contentIds":[
"mk19_b_cv_v05",
"mk19_b_cv_t21"
]
},
{
"type":"p",
"hlId":"9736e1",
"children":[
"TTE is highly accurate for assessing disease severity, pulmonary pressures, and RV function as well as for identifying concomitant valvular lesions (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t23",
"wrapId":"13",
"children":[
"Table 23"
]
}
]
},
")"
]
},
". Additional imaging studies or cardiac catheterization is rarely required for diagnosis. Severe mitral stenosis is defined by a mitral valve area of 1.5 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
" or less, which usually corresponds to a mean mitral gradient of more than 5 to 10 mm Hg at a normal heart rate. In patients with a discrepancy between the clinical and echocardiographic findings, exercise echocardiography or exercise testing during cardiac catheterization should be pursued to assess the response of the mitral gradient and pulmonary pressures."
]
},
{
"type":"inline-wrap",
"wrapId":"13",
"contentIds":[
"mk19_b_cv_t23"
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_5_2",
"title":{
"__html":"Management"
},
"titleNode":{
"type":"section-title",
"hlId":"fe4dbc",
"children":[
"Management"
]
},
"children":[
{
"type":"p",
"hlId":"121537",
"children":[
"Percutaneous balloon mitral commissurotomy (PBMC) is the procedure of choice for patients with significant rheumatic mitral stenosis when the valve is pliable and not severely calcified. PBMC is indicated for symptomatic patients with severe rheumatic mitral stenosis and favorable valve morphology and is reasonable in asymptomatic patients with severe rheumatic mitral stenosis and a pulmonary artery systolic pressure greater than 50 mm Hg. PBMC should not be performed in patients with LA thrombus or moderate or severe mitral regurgitation, both of which are optimally evaluated with TEE. In appropriately selected patients, the success rate with PBMC is 95%, and complications occur in fewer than 5% of patients. Mitral valve surgery is indicated in patients with severe mitral stenosis, New York Heart Association functional class III or IV symptoms, and a nonpliable valve and in asymptomatic patients with severe mitral stenosis undergoing concomitant cardiac surgery for another indication."
]
},
{
"type":"p",
"hlId":"cefcc0",
"children":[
"Nearly 50% of patients with mitral stenosis have atrial fibrillation, and without anticoagulation, these patients have a risk for thromboembolism of 20% to 25%. Patients with moderate to severe mitral stenosis and concomitant atrial fibrillation should receive a vitamin K antagonist such as warfarin, with a goal INR of 2.0 to 3.0. Anticoagulation is also indicated in patients with a history of LA thrombus or systemic embolization. Notably, clinical trials of direct-acting oral anticoagulants in atrial fibrillation excluded patients with moderate to severe mitral stenosis; therefore, the efficacy and safety of these agents have not been demonstrated in this population."
]
},
{
"type":"p",
"hlId":"c5011c",
"children":[
"Because the mitral gradient is heavily dependent on transvalvular flow, medical therapy with negative chronotropic agents, diuretics, and long-acting nitrates can be effective for symptom palliation in patients who are not candidates for interventional or surgical therapy."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"dacb87",
"children":[
"In patients with mitral stenosis, transthoracic echocardiography is highly accurate for assessing disease severity, pulmonary pressures, and right ventricular function as well as identifying concomitant valvular lesions."
]
},
{
"type":"keypoint",
"hlId":"0dde61",
"children":[
"Percutaneous balloon mitral commissurotomy is indicated for patients with symptomatic severe mitral stenosis and favorable valve morphology."
]
},
{
"type":"keypoint",
"hlId":"3f954e",
"children":[
"Anticoagulation is recommended for patients with mitral stenosis and a history of atrial fibrillation, left atrial thrombus, or systemic embolization."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_6",
"title":{
"__html":"Mitral Regurgitation"
},
"titleNode":{
"type":"section-title",
"hlId":"c3e60a",
"children":[
"Mitral Regurgitation"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_cv_s6_6_1",
"title":{
"__html":"Clinical Presentation and Evaluation"
},
"titleNode":{
"type":"section-title",
"hlId":"727f2a",
"children":[
"Clinical Presentation and Evaluation"
]
},
"children":[
{
"type":"p",
"hlId":"c23041",
"children":[
"Mitral regurgitation may arise from dysfunction of any portion of the complex valve apparatus (leaflets, annulus, chordae, papillary muscles, or LV free walls) and may present acutely or chronically. Causes of acute mitral regurgitation include infective endocarditis, papillary muscle ischemia or rupture, trauma (e.g., injury from PBMC or blunt force), or degenerative disease with chordal rupture and flail leaflet. Chronic mitral regurgitation is classified as primary, involving any portion of the mitral annulus, or secondary, involving causes other than the annulus (e.g., ventricular dysfunction). Common causes of primary mitral regurgitation are mitral valve prolapse (also known as myxomatous or degenerative mitral valve disease), radiation therapy, rheumatic disease, and cleft mitral valve."
]
},
{
"type":"p",
"hlId":"ca18c2",
"children":[
"Mitral regurgitation results in volume overload with LV dilatation and LA hypertension, which may progress and cause pulmonary hypertension and RV failure. In acute mitral regurgitation, heart failure symptoms often occur abruptly because of insufficient time for adaptive chamber dilatation and, in some patients, can result in cardiogenic shock. The systolic murmur in acute mitral regurgitation may be brief because of the rapid equalization of LA and LV pressures, and echocardiography with color flow imaging can underestimate the severity of the regurgitation. Thus, when acute mitral regurgitation is suspected, comprehensive assessment to identify the potential causes should be pursued, and additional imaging with TEE should be considered."
]
},
{
"type":"p",
"hlId":"b2d6ce",
"children":[
"Chronic primary mitral regurgitation is predominantly caused by mitral valve prolapse, which affects approximately 2% of the general population in the United States. Echocardiography in patients with chronic primary mitral regurgitation may show a range of abnormalities, including prolapse ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_cv_f34",
"wrapId":"14",
"children":[
"Figure 34"
]
}
]
},
")"
]
},
", gross degeneration of one or both leaflets (Barlow syndrome), or chordal rupture with flail leaflet. Barlow syndrome is more common in young adult patients. In patients who are relatively older, fibroelastic deficiency predominates and frequently results in chordal rupture. In patients with chronic secondary mitral regurgitation, ventricular dysfunction causes mitral regurgitation through papillary muscle displacement and tethering of the mitral leaflets, which impairs coaptation. The mitral valve apparatus is normal in patients with chronic secondary mitral regurgitation ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_cv_f35",
"wrapId":"14",
"children":[
"Figure 35"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"14",
"contentIds":[
"mk19_b_cv_f34",
"mk19_b_cv_f35"
]
},
{
"type":"p",
"hlId":"9441ba",
"children":[
"The physical examination in patients with chronic mitral regurgitation is notable for a blowing holosystolic murmur at the apex (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_b_cv_v06",
"wrapId":"15",
"children":[
"Video 6"
]
}
]
},
"). In patients with mitral valve prolapse, one or more systolic clicks may precede the murmur (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"video-link",
"target":"mk19_b_cv_v07",
"wrapId":"15",
"children":[
"Video 7"
]
}
]
},
"), and variation in severity, preload, and afterload can lead to differences in murmur onset (holosystolic, midsystolic, or late systolic). In patients with LV dilatation, the apical impulse may be displaced laterally, and an S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"3"
]
},
" may be audible, especially in patients with secondary mitral regurgitation due to LV dysfunction."
]
},
{
"type":"inline-wrap",
"wrapId":"15",
"contentIds":[
"mk19_b_cv_v06",
"mk19_b_cv_v07"
]
},
{
"type":"p",
"hlId":"2d2a0d",
"children":[
"TTE readily and accurately assesses the severity of primary mitral regurgitation. Severe primary mitral regurgitation is defined by several parameters, the most common of which are an effective regurgitant orifice area of 0.4 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
" or larger, regurgitant volume of 60 mL or more, and vena contracta of 0.7 cm or larger. When TTE provides insufficient or discordant information, TEE or CMR imaging is indicated."
]
},
{
"type":"p",
"hlId":"3b3211",
"children":[
"Appropriate follow-up of asymptomatic patients with mitral regurgitation is outlined in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t23",
"wrapId":"16",
"children":[
"Table 23"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"16",
"contentIds":[
"mk19_b_cv_t23"
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_6_2",
"title":{
"__html":"Management"
},
"titleNode":{
"type":"section-title",
"hlId":"fe4dbc",
"children":[
"Management"
]
},
"children":[
{
"type":"p",
"hlId":"01799d",
"children":[
"Medical therapy and surgical intervention can be life-saving in patients with acute severe mitral regurgitation. Vasodilator therapy with a titratable drug, such as nitroprusside, decreases aortic impedance and mitral regurgitation, thereby improving forward cardiac output. An intra-aortic balloon pump can be used to decrease afterload and augment systemic and coronary perfusion pressures. Prompt surgical correction should be considered for all patients with acute severe mitral regurgitation."
]
},
{
"type":"p",
"hlId":"dd6f45",
"children":[
"Patients with chronic severe primary mitral regurgitation generally do poorly without surgery, particularly when there are significant symptoms, flail leaflet, or LV dilatation. In one study of 458 patients with asymptomatic severe primary mitral regurgitation, the 5-year survival rate was only 58%. Surgical repair of the mitral valve is indicated for chronic severe primary mitral regurgitation in symptomatic patients (regardless of LV systolic function) and asymptomatic patients with LV dysfunction (ejection fraction ≤60% and/or LV end-systolic dimension ≥40 mm). Surgical repair is reasonable in asymptomatic patients with preserved LV function when the expected repair success rate is greater than 95% and the operative risk is less than 1%. Surgical repair is preferred over replacement in all patients, and patients should be referred to a surgical center with expertise to improve the chances of repair. Medical therapy with vasodilators is not beneficial in patients with primary mitral regurgitation in the absence of symptoms or LV dysfunction."
]
},
{
"type":"p",
"hlId":"724e69",
"children":[
"For patients who are not surgical candidates, transcatheter mitral valve repair with a clip device (transcatheter edge-to-edge repair [TEER]) improves coaptation of the mitral valve leaflets, leading to increased valve closure and a reduction in regurgitation ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_cv_f36",
"wrapId":"17",
"children":[
"Figure 36"
]
}
]
},
")"
]
},
". In selected patients with primary mitral regurgitation, success rates with TEER are approximately 90%, with a procedural mortality rate of approximately 2%."
]
},
{
"type":"inline-wrap",
"wrapId":"17",
"contentIds":[
"mk19_b_cv_f36"
]
},
{
"type":"p",
"hlId":"c8caef",
"children":[
"In patients with chronic secondary mitral regurgitation, the primary goal of therapy is to address the underlying ventricular dysfunction with guideline-directed medical therapy and, if indicated, cardiac resynchronization therapy (see ",
{
"type":"cross-reference",
"target":"mk19_b_cv_s4_4_1_2",
"children":[
"Heart Failure"
]
},
"). Guideline-directed medical therapy for ventricular dysfunction includes an ACE inhibitor, ARB, or angiotensin receptor–neprilysin inhibitor; a β-blocker; a diuretic; and/or an aldosterone antagonist. Benefits of valve repair or replacement in patients with secondary mitral regurgitation are less certain, although studies have demonstrated favorable LV remodeling after surgery. Surgery for secondary severe mitral regurgitation is reasonable for those undergoing coronary artery bypass grafting, but mitral regurgitation may recur after repair because of primary LV dysfunction. TEER has been approved by the FDA for patients with chronic secondary mitral regurgitation and refractory symptoms despite optimal medical therapy for heart failure; however, the effect of TEER on mortality and heart failure hospitalization in this population has varied in studies."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"d1dc2b",
"children":[
"Patients with acute mitral regurgitation may present with acute heart failure; these patients may be difficult to diagnose clinically or with echocardiography."
]
},
{
"type":"keypoint",
"hlId":"37f337",
"children":[
"Surgery for chronic severe primary mitral regurgitation is indicated in the presence of symptoms, left ventricular dilatation, or decreasing ejection fraction."
]
},
{
"type":"keypoint",
"hlId":"17fe58",
"children":[
"Surgical repair is preferred over replacement in patients with chronic primary mitral regurgitation; patients should be referred to a surgical center with expertise to improve the chances of repair."
]
},
{
"type":"keypoint",
"hlId":"bfbaf1",
"children":[
"Transcatheter mitral valve repair with implantation of a clip device may be considered for patients with chronic severe primary mitral regurgitation who are at high surgical risk."
]
},
{
"type":"keypoint",
"hlId":"b3aeeb",
"children":[
"Patients with chronic secondary mitral regurgitation should be treated with guideline-directed medical therapy for ventricular dysfunction; surgical intervention may be considered for those undergoing concomitant cardiac surgery."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_7",
"title":{
"__html":"Tricuspid Valve Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"e98a08",
"children":[
"Tricuspid Valve Disease"
]
},
"children":[
{
"type":"p",
"hlId":"9e7ac6",
"children":[
"Tricuspid regurgitation, the most common form of tricuspid valve disease, is frequently functional (or secondary) and clinically asymptomatic. Causes of tricuspid regurgitation include cor pulmonale (or pulmonary hypertension) with RV failure, pacemaker or defibrillator lead placement, trauma, congenital abnormalities, and infective endocarditis. When symptomatic, patients may present with fatigue from low cardiac output as well as signs and symptoms of right-sided failure, such as elevated jugular venous pulse (a large ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"c-v"
]
},
" wave), a palpable RV lift, hepatic congestion with pulsatile liver, and peripheral edema. The murmur of tricuspid regurgitation is typically a holosystolic murmur heard along the left sternal border that increases during inspiration due to increased venous return."
]
},
{
"type":"p",
"hlId":"ebaa02",
"children":[
"Tricuspid regurgitation should be evaluated with TTE, which also allows assessment of RV function and estimation of pulmonary pressures. In patients with tricuspid regurgitation due to pacemaker or defibrillator lead placement, TEE may be required to determine the etiology more clearly."
]
},
{
"type":"p",
"hlId":"48259b",
"children":[
"Medical therapy with loop diuretics and aldosterone antagonists alleviates symptoms of right-sided congestion; risks include low-flow state with impaired cardiac output. Surgery is recommended for patients with severe tricuspid regurgitation who are undergoing left-sided valve surgery. Surgery may be considered in patients with severe symptomatic tricuspid regurgitation refractory to medical therapy."
]
},
{
"type":"p",
"hlId":"eb302a",
"children":[
"Tricuspid stenosis is almost always caused by rheumatic disease. Other causes include radiation therapy, carcinoid syndrome, and medications (e.g., the ergot agent cabergoline). Symptoms of tricuspid stenosis (fatigue, cold skin) are typically overshadowed by those caused by the left-sided abnormalities of coexistent rheumatic mitral disease. Clinical findings include signs of right-sided congestion (elevated jugular venous pulse, hepatic congestion, peripheral edema) and a diastolic rumble. Surgery for tricuspid stenosis is typically performed in concert with therapy for rheumatic mitral disease."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"325dca",
"children":[
"Loop diuretics and aldosterone antagonists alleviate symptoms of right-sided congestion in patients with significant tricuspid regurgitation."
]
},
{
"type":"keypoint",
"hlId":"5b7ba7",
"children":[
"Tricuspid valve surgery is recommended for patients with severe tricuspid regurgitation undergoing left-sided valve surgery and may be considered in patients with severe symptomatic tricuspid regurgitation refractory to medical therapy."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_8",
"title":{
"__html":"Prosthetic Valves"
},
"titleNode":{
"type":"section-title",
"hlId":"3955c9",
"children":[
"Prosthetic Valves"
]
},
"children":[
{
"type":"p",
"hlId":"4cc52f",
"children":[
"The choice of prosthesis in a patient undergoing surgical valve replacement is multifactorial, considering the patient's age, the expected durability of the prosthesis, the surgical risk for reoperation in the event of degeneration, and the ability and willingness of the patient to take warfarin for anticoagulation. For patients of any age, a bioprosthetic valve is recommended for patients who cannot or do not desire to take anticoagulation therapy. According to the American College of Cardiology/American Heart Association, an aortic mechanical valve is reasonable in patients younger than 50 years, a bioprosthesis is reasonable in patients older than 65 years, and either a bioprosthesis or mechanical aortic valve prosthesis is reasonable in those aged 50 to 65 years. In patients older than age 65 years, a mitral valve bioprosthesis is reasonable, as is mechanical valve prosthesis in patients younger than 65 years. However, the final decision on valve type should be reached through a shared decision-making process between the physician and patient."
]
},
{
"type":"p",
"hlId":"5bae2b",
"children":[
"The expected durability of bioprostheses is 15 years, and in persons younger than 60 years, approximately 40% of valves have evidence of clinically severe deterioration by 15 years. Data on long-term durability of TAVI prostheses are currently limited to a follow-up of 8 to 10 years; however, thus far, valve durability is similar to surgical prostheses."
]
},
{
"type":"p",
"hlId":"7436a5",
"children":[
"Echocardiography should be performed after implantation to document the baseline hemodynamic performance of the valve, and repeat evaluations should be performed for signs or symptoms of prosthetic dysfunction (new dyspnea or heart failure, louder murmur or new murmur, thromboembolism, hemolytic anemia). In patients with a surgical bioprosthetic valve, TTE at 5 years and 10 years and then annually after implantation is reasonable, even in the absence of a change in clinical status. For patients with a transcatheter bioprosthetic valve, annual TTE is reasonable, even in the absence of a change in clinical status."
]
},
{
"type":"p",
"hlId":"da4c13",
"children":[
"Lifelong warfarin anticoagulation is indicated for all patients with a mechanical valve. Therapy should target a specific INR value rather than a range. In patients with a mechanical aortic valve prosthesis (bileaflet or current-generation single-tilting disc) with no additional risk factors for thromboembolism (history of embolization, hypercoagulable disorder, LV dysfunction, atrial fibrillation), the goal INR for warfarin anticoagulation is 2.5. In patients with a mechanical aortic valve prosthesis with heightened risk factors for thromboembolism, an older-generation aortic valve prosthesis (ball-in-cage), or any mitral prosthesis, the target INR is 3.0. An INR range of 2.5 to 3.5 is acceptable to balance the risks of under- and over-anticoagulation in a patient with a mechanical mitral valve. Because of the risk for valve thrombosis, direct-acting oral anticoagulants should not be used for anticoagulation in patients with a mechanical valve. Oral anticoagulation with warfarin should be considered for 3 to 6 months after implantation of a mitral or aortic bioprosthesis. An INR of 2.5 should be targeted in these patients."
]
},
{
"type":"p",
"hlId":"4ea8ca",
"children":[
"Adding aspirin (75-100 mg/d) to warfarin in patients with a mechanical prosthesis decreases the risk for stroke and death and may be considered in patients who have an indication for antiplatelet therapy when the bleeding risk is low. Low-dose aspirin is reasonable for all patients with a bioprosthesis."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"43443d",
"children":[
"A shared decision-making process should guide the choice of prosthetic aortic valve type, especially in patients aged 50 to 65 years, in whom either a mechanical valve or bioprosthesis is a reasonable choice."
]
},
{
"type":"keypoint",
"hlId":"9c1669",
"children":[
"Echocardiography is recommended for all patients with a surgical bioprosthesis at baseline, 5 and 10 years after surgery, and then annually thereafter and with any change in clinical status suggesting prosthetic dysfunction."
]
},
{
"type":"keypoint",
"hlId":"ecce93",
"children":[
"Echocardiography is recommended for all patients with a transcatheter bioprosthesis at baseline and annually thereafter and with any change in clinical status suggesting prosthetic valve dysfunction."
]
},
{
"type":"keypoint",
"hlId":"ec9883",
"children":[
"Lifelong warfarin anticoagulation is recommended in all patients with a mechanical valve prosthesis; low-dose aspirin is reasonable for all patients with a bioprosthesis."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_9",
"title":{
"__html":"Infective Endocarditis"
},
"titleNode":{
"type":"section-title",
"hlId":"b92cb6",
"children":[
"Infective Endocarditis"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_cv_s6_9_1",
"title":{
"__html":"Diagnosis and Management"
},
"titleNode":{
"type":"section-title",
"hlId":"cf968b",
"children":[
"Diagnosis and Management"
]
},
"children":[
{
"type":"p",
"hlId":"2d1daa",
"children":[
"Infective endocarditis (IE) is a life-threatening bacterial or fungal infection of the endocardium involving native valvular structures or implanted cardiac devices. Such devices include cardiac valve prostheses, permanent pacemakers, implanted cardioverter-defibrillators, and occluders for repair of congenital lesions (e.g., atrial or ventricular septal defect occluders). Risk factors for IE include advanced age, diabetes mellitus, immunosuppression, injection drug use, indwelling intravenous catheters, congenital heart disease, cardiac transplantation with valvulopathy, and an implanted cardiac device. IE carries significant risk for morbidity and mortality, with high rates of in-hospital mortality (20%), 1-year mortality (40%), peripheral embolization (23%), stroke (17%), and need for cardiac surgery (48%). Early diagnosis, targeted antimicrobial therapy, and recognition of the need for early surgical intervention enhance patient survival."
]
},
{
"type":"p",
"hlId":"141437",
"children":[
"Many of the clinical manifestations of IE are nonspecific, and a high index of suspicion is necessary to make the diagnosis. Findings that should prompt consideration of IE include fever without a clear alternate cause, a new cardiac murmur, and septic emboli. Physical findings such as splinter hemorrhages, conjunctival hemorrhage, Osler nodes (violaceous, circumscribed, painful nodules found in the pulp of the fingers and toes), Janeway lesions (painless, erythematous, macular lesions found on the soles and palms), and Roth spots (hemorrhagic lesions of the retina) also suggest the diagnosis."
]
},
{
"type":"p",
"hlId":"436a51",
"children":[
"Diagnosis of definite IE requires pathologic confirmation of microorganisms demonstrated by culture or histologic examination of a vegetation, a vegetation that has embolized, or an intracardiac abscess specimen. Much more commonly, the diagnosis is made using the modified Duke criteria ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t24",
"wrapId":"18",
"children":[
"Table 24"
]
}
]
},
")"
]
},
". The diagnostic criteria for definite IE include either two major criteria, one major criterion plus three minor criteria, or five minor criteria. Possible IE requires one major criterion and one minor criterion, or three minor criteria. IE is excluded when there is a firm alternative diagnosis, resolution of IE syndrome with antibiotic therapy for 4 days or less, or no pathologic evidence of IE at surgery or at autopsy with antibiotic therapy for 4 days or less."
]
},
{
"type":"inline-wrap",
"wrapId":"18",
"contentIds":[
"mk19_b_cv_t24"
]
},
{
"type":"p",
"hlId":"971afa",
"children":[
"Blood cultures are positive in 90% of IE cases. Most cases of culture-negative endocarditis occur in patients who have received recent pre-culture antibiotics. Serologic testing may be required to identify fastidious organisms that are difficult to culture. In patients with a prosthetic valve, IE syndrome is classified according to the time from surgery as early (within 60 days), intermediate (60-365 days), and late (>365 days). Early prosthetic valve endocarditis (PVE) is characterized by infection with hospital-acquired microbes, such as ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Staphylococcus aureus"
]
},
". Coagulase-negative staphylococci are the most common microbes in intermediate PVE. ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"S. aureus"
]
},
" and coagulase-negative staphylococci are important causes of late PVE; however, the microbes in late PVE more typically resemble those of native valve endocarditis."
]
},
{
"type":"p",
"hlId":"4ed305",
"children":[
"TTE is indicated to identify vegetations and associated hemodynamic derangements. TEE is indicated with intermediate or high suspicion for IE when TTE is not diagnostic, especially in the setting of a prosthetic valve, intracardiac device, or myocardial abscess, which in turn is suggested by new conduction abnormalities on ECG or persistent bacteremia despite antibiotic therapy. In patients with IE who have a change in clinical signs or symptoms, TTE and/or TEE are recommended for reevaluation."
]
},
{
"type":"p",
"hlId":"bcbd02",
"children":[
"Appropriate antimicrobial therapy should be promptly initiated in high-risk patients, such as those with severe sepsis, once cultures have been obtained. Empiric treatment should consider patient risk factors, such as intravenous drug use or the presence of an indwelling intravenous catheter, and focus on the most common causes of acute endocarditis—",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Staphylococcus"
]
},
" (methicillin susceptible and methicillin resistant), ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Streptococcus"
]
},
", and ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Enterococcus"
]
},
" species. Regimens for empiric antibiotic therapy in critically ill patients with acute endocarditis are provided in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t25",
"wrapId":"19",
"children":[
"Table 25"
]
}
]
},
". Antimicrobials should not be administered to patients with VHD and unexplained fever before several blood cultures are drawn. Empiric antibiotic combinations can be more focused when microbiologic results are available. Infectious disease consultants should advise on the duration of therapy."
]
},
{
"type":"inline-wrap",
"wrapId":"19",
"contentIds":[
"mk19_b_cv_t25"
]
},
{
"type":"p",
"hlId":"be26fd",
"children":[
"The decision to pursue surgery for treatment of IE and the timing of such surgery is complex and requires a multidisciplinary approach. Early surgery (during hospitalization and before completion of an antimicrobial course) is recommended for patients with any of the following:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"16d06f",
"children":[
"Severe valvular dysfunction resulting in symptomatic heart failure"
]
},
" ",
{
"type":"list-item",
"hlId":"06bf04",
"children":[
"Left-sided IE caused by ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"S. aureus"
]
},
", fungal infections, or other highly resistant organisms"
]
},
" ",
{
"type":"list-item",
"hlId":"660ac9",
"children":[
"Associated complications, such as annular or aortic abscess, destructive penetrating lesions, or heart block"
]
},
" ",
{
"type":"list-item",
"hlId":"ba29eb",
"children":[
"Persistent bacteremia or fevers lasting longer than 5 to 7 days after onset of appropriate antimicrobial therapy"
]
},
" "
]
},
{
"type":"p",
"hlId":"f6da19",
"children":[
"Early surgery is reasonable in patients with recurrent emboli and persistent valve vegetations despite 5 to 7 days of antibiotic therapy, and early surgery may be considered in the presence of a large (>10-mm) left-sided vegetation to prevent embolic events. When IE is associated with a pacemaker or defibrillator, the entire system (generator and leads) must be removed."
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_9_2",
"title":{
"__html":"Prophylaxis"
},
"titleNode":{
"type":"section-title",
"hlId":"264e21",
"children":[
"Prophylaxis"
]
},
"children":[
{
"type":"p",
"hlId":"ccbcda",
"children":[
"Endocarditis prophylaxis is recommended for a specific group of patients before dental procedures that involve manipulation of gingival tissue or the periapical region of the teeth or perforation of the oral mucosa ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_cv_t26",
"wrapId":"20",
"children":[
"Table 26"
]
}
]
},
")"
]
},
". Although endocarditis prophylaxis was previously advised for a broad population, current guidelines recommend its use only for the following:"
]
},
{
"type":"inline-wrap",
"wrapId":"20",
"contentIds":[
"mk19_b_cv_t26"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"34328a",
"children":[
"History of endocarditis"
]
},
" ",
{
"type":"list-item",
"hlId":"2675c7",
"children":[
"Cardiac transplantation with valve regurgitation due to a structurally abnormal valve"
]
},
" ",
{
"type":"list-item",
"hlId":"d26d73",
"children":[
"Prosthetic valve"
]
},
" ",
{
"type":"list-item",
"hlId":"0f35db",
"children":[
"Prosthetic material used for cardiac valve repair, including annuloplasty rings and clips"
]
},
" ",
{
"type":"list-item",
"hlId":"4d7831",
"children":[
"Left ventricular assist device"
]
},
" ",
{
"type":"list-item",
"hlId":"2bce9d",
"children":[
"Unrepaired congenital heart disease"
]
},
" ",
{
"type":"list-item",
"hlId":"8c76ba",
"children":[
"Repaired congenital heart disease with residual defects at the site or adjacent to the site of a prosthetic patch or device"
]
},
" ",
{
"type":"list-item",
"hlId":"680339",
"children":[
"A defect that has been repaired with prosthetic material (surgical or catheter-based) within the previous 6 months"
]
},
" ",
{
"type":"list-item",
"hlId":"86a3bb",
"children":[
"Surgical or transcatheter pulmonary artery valve or conduit placement, such as Melody valve and Contegra conduit"
]
},
" "
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"954424",
"children":[
"Initial diagnostic tests for suspected infective endocarditis (IE) include blood cultures and transthoracic echocardiography (TTE); TTE is followed by transesophageal echocardiography in patients with suboptimal TTE results or with high initial risk for IE."
]
},
{
"type":"keypoint",
"hlId":"dbb017",
"children":[
"Early surgery is indicated for patients with acute infective endocarditis (IE) presenting with acute and worsening valve regurgitation resulting in heart failure; left-sided IE caused by ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Staphylococcus aureus"
]
},
", fungal, or other highly resistant organisms; IE complicated by heart block, annular or aortic abscess, or destructive penetrating lesion; and IE with persistent bacteremia or fevers lasting longer than 5 to 7 days after starting antibiotic therapy."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_cv_s6_10",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Baddour LM, Wilson WR, Bayer AS, et al; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435-86. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26373316",
"target":"_blank"
},
"children":[
"PMID: 26373316"
]
},
" doi:10.1161/CIR.0000000000000296"
]
},
{
"type":"reference",
"children":[
"Dangas GD, Weitz JI, Giustino G, et al. Prosthetic heart valve thrombosis. J Am Coll Cardiol. 2016;68:2670-2689. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27978952",
"target":"_blank"
},
"children":[
"PMID: 27978952"
]
},
" doi:10.1016/j.jacc.2016.09.958"
]
},
{
"type":"reference",
"children":[
"Eikelboom JW, Connolly SJ, Brueckmann M, et al; RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206-14. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/23991661",
"target":"_blank"
},
"children":[
"PMID: 23991661"
]
},
" doi:10.1056/NEJMoa1300615"
]
},
{
"type":"reference",
"children":[
"Makkar RR, Thourani VH, Mack MJ, et al; PARTNER 2 Investigators. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382:799-809. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31995682",
"target":"_blank"
},
"children":[
"PMID: 31995682"
]
},
" doi:10.1056/NEJMoa1910555"
]
},
{
"type":"reference",
"children":[
"Murdoch DR, Corey GR, Hoen B, et al; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463-73. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/19273776",
"target":"_blank"
},
"children":[
"PMID: 19273776"
]
},
" doi:10.1001/archinternmed.2008.603"
]
},
{
"type":"reference",
"children":[
"Obadia JF, Messika-Zeitoun D, Leurent G, et al; MITRA-FR Investigators. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297-2306. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30145927",
"target":"_blank"
},
"children":[
"PMID: 30145927"
]
},
" doi:10.1056/NEJMoa1805374"
]
},
{
"type":"reference",
"children":[
"Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72-e227. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33332150",
"target":"_blank"
},
"children":[
"PMID: 33332150"
]
},
" doi:10.1161/CIR.0000000000000923"
]
},
{
"type":"reference",
"children":[
"Ribeiro HB, Lerakis S, Gilard M, et al. Transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis: the TOPAS-TAVI registry. J Am Coll Cardiol. 2018;71:1297-1308. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29566812",
"target":"_blank"
},
"children":[
"PMID: 29566812"
]
},
" doi:10.1016/j.jacc.2018.01.054"
]
},
{
"type":"reference",
"children":[
"Stone GW, Lindenfeld J, Abraham WT, et al; COAPT Investigators. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307-2318. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30280640",
"target":"_blank"
},
"children":[
"PMID: 30280640"
]
},
" doi:10.1056/NEJMoa1806640"
]
},
{
"type":"reference",
"children":[
"Suri RM, Vanoverschelde JL, Grigioni F, et al. Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA. 2013;310:609-16. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/23942679",
"target":"_blank"
},
"children":[
"PMID: 23942679"
]
},
" doi:10.1001/jama.2013.8643"
]
},
{
"type":"reference",
"children":[
"Thornhill MH, Gibson TB, Cutler E, et al. Antibiotic prophylaxis and incidence of endocarditis before and after the 2007 AHA recommendations. J Am Coll Cardiol. 2018;72:2443-2454. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30409564",
"target":"_blank"
},
"children":[
"PMID: 30409564"
]
},
" doi:10.1016/j.jacc.2018.08.2178"
]
},
{
"type":"reference",
"children":[
"Wilson WR, Gewitz M, Lockhart PB, et al; American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and the Council on Quality of Care and Outcomes Research. Prevention of Viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation. 2021;143:e963-e978. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33853363",
"target":"_blank"
},
"children":[
"PMID: 33853363"
]
},
" doi:10.1161/CIR.0000000000000969"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_b_cv_t21":{
"id":"mk19_b_cv_t21",
"number":21,
"bookId":"cv",
"title":{
"__html":"Valvular and Other Cardiac Lesions and Their Associated Examination Findings"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"5f75f3",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 21. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_cv_t21"
}
]
},
"Valvular and Other Cardiac Lesions and Their Associated Examination Findings"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3f7c46",
"class":"col hd l",
"children":[
"Cardiac Condition"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"43c194",
"class":"col hd l",
"children":[
"Characteristic Murmur"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ce5bf5",
"class":"col hd l",
"children":[
"Location"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bff9b6",
"class":"col hd l",
"children":[
"Radiation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8a3f6e",
"class":"col hd l",
"children":[
"Associated Findings"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ae1f34",
"class":"col hd l",
"children":[
"Severity and Pitfalls"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b074e0",
"class":"cell txt l",
"children":[
"Aortic stenosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89ef55",
"class":"cell txt l",
"children":[
"Midsystolic; crescendo-decrescendo"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c7d4fe",
"class":"cell txt l",
"children":[
"RUSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5f9d40",
"class":"cell txt l",
"children":[
"Right clavicle, carotid; apex"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1c597d",
"class":"cell txt l",
"children":[
"Enlarged, nondisplaced apical impulse; S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"4"
]
},
"; bicuspid valve without calcification will have systolic ejection click followed by murmur"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"da1e87",
"class":"cell txt l",
"children":[
"Severe aortic stenosis findings may include decreased A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"; high-pitched, late-peaking murmur; diminished and delayed carotid upstroke; radiation of murmur to both clavicles and carotids"
]
},
" ",
{
"type":"p",
"hlId":"b8f272",
"class":"cell txt l",
"children":[
"Radiation of murmur down the descending thoracic aorta may mimic mitral regurgitation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd7b47",
"class":"cell txt l",
"children":[
"Aortic regurgitation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c084f",
"class":"cell txt l",
"children":[
"Diastolic; decrescendo"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b9ff21",
"class":"cell txt l",
"children":[
"LLSB (valvular) or RLSB (dilated aorta) (best heard sitting and leaning forward)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f788b8",
"class":"cell txt l",
"children":[
"Enlarged, displaced apical impulse; S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"3"
]
},
" or S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"4"
]
},
"; increased pulse pressure; bounding carotid and peripheral pulses"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6b9085",
"class":"cell txt l",
"children":[
"Acute severe regurgitation murmur may be masked by tachycardia and short duration of murmur"
]
},
" ",
{
"type":"p",
"hlId":"43f499",
"class":"cell txt l",
"children":[
"Severity in chronic regurgitation is difficult to assess by auscultation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"94a791",
"class":"cell txt l",
"children":[
"Mitral stenosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"06182d",
"class":"cell txt l",
"children":[
"Diastolic; low-pitched, decrescendo"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"45c827",
"class":"cell txt l",
"children":[
"Apex (best heard in left lateral decubitus position)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3ece45",
"class":"cell txt l",
"children":[
"Loud S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
"; tapping apex beat; opening snap after S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" if leaflets mobile; irregular pulse if atrial fibrillation present"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8cc794",
"class":"cell txt l",
"children":[
"Interval between S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" and opening snap is short in severe mitral stenosis"
]
},
" ",
{
"type":"p",
"hlId":"834a8f",
"class":"cell txt l",
"children":[
"Intensity of murmur correlates with transvalvular gradient"
]
},
" ",
{
"type":"p",
"hlId":"e71ae3",
"class":"cell txt l",
"children":[
"P",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" may be loud if pulmonary hypertension present"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"23837e",
"class":"cell txt l",
"children":[
"Mitral regurgitation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b9b85b",
"class":"cell txt l",
"children":[
"Systolic; holo-, mid-, or late systolic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2eb09d",
"class":"cell txt l",
"children":[
"Apex"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7c744c",
"class":"cell txt l",
"children":[
"Axilla or back; occasionally anteriorly to precordium"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"073af9",
"class":"cell txt l",
"children":[
"Systolic click in mitral valve prolapse; S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"3"
]
},
"; apical impulse hyperdynamic and may be displaced if dilated left ventricle; in mitral valve prolapse, Valsalva maneuver moves onset of clicks and murmur closer to S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
"; handgrip maneuver increases murmur intensity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ca1bea",
"class":"cell txt l",
"children":[
"Acute severe regurgitation may have soft or no holosystolic murmur, mitral inflow rumble, or S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"3"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4cb3a7",
"class":"cell txt l",
"children":[
"Tricuspid regurgitation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd2ed7",
"class":"cell txt l",
"children":[
"Holosystolic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b8459",
"class":"cell txt l",
"children":[
"LLSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a51db9",
"class":"cell txt l",
"children":[
"LUSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"56b135",
"class":"cell txt l",
"children":[
"Merged and prominent ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"c"
]
},
" and ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"v"
]
},
" waves in jugular venous pulse; murmur increases during inspiration"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4804ac",
"class":"cell txt l",
"children":[
"Right ventricular impulse below sternum"
]
},
" ",
{
"type":"p",
"hlId":"2845c1",
"class":"cell txt l",
"children":[
"Pulsatile, enlarged liver with possible ascites"
]
},
" ",
{
"type":"p",
"hlId":"787e8b",
"class":"cell txt l",
"children":[
"Murmur may be high-pitched if associated with severe pulmonary hypertension"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"340963",
"class":"cell txt l",
"children":[
"Tricuspid stenosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"88da22",
"class":"cell txt l",
"children":[
"Diastolic; low-pitched, decrescendo; increased intensity during inspiration"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b8459",
"class":"cell txt l",
"children":[
"LLSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d6eb2d",
"class":"cell txt l",
"children":[
"Elevated central venous pressure with prominent ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"a"
]
},
" wave, signs of venous congestion (hepatomegaly, ascites, edema)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0848c5",
"class":"cell txt l",
"children":[
"Low-pitched frequency may be difficult to auscultate, especially at higher heart rate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"46d71b",
"class":"cell txt l",
"children":[
"Pulmonary valve stenosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9f22e9",
"class":"cell txt l",
"children":[
"Systolic; crescendo-decrescendo"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a51db9",
"class":"cell txt l",
"children":[
"LUSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6e3e7c",
"class":"cell txt l",
"children":[
"Left clavicle"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"559bc3",
"class":"cell txt l",
"children":[
"Pulmonic ejection click after S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
" (diminishes with inspiration)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"15c5e4",
"class":"cell txt l",
"children":[
"Increased intensity of murmur with late peaking"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f3d51c",
"class":"cell txt l",
"children":[
"Pulmonary valve regurgitation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c084f",
"class":"cell txt l",
"children":[
"Diastolic; decrescendo"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b8459",
"class":"cell txt l",
"children":[
"LLSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21d67c",
"class":"cell txt l",
"children":[
"Loud P",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" if pulmonary hypertension present"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"50ffde",
"class":"cell txt l",
"children":[
"Murmur may be minimal or absent if severe due to minimal difference in pulmonary artery and right ventricular diastolic pressures"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b843ea",
"class":"cell txt l",
"children":[
"Benign (innocent) flow murmur"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8be1e3",
"class":"cell txt l",
"children":[
"Midsystolic; grade 1/6 or 2/6 in intensity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c7d4fe",
"class":"cell txt l",
"children":[
"RUSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"851f17",
"class":"cell txt l",
"children":[
"Normal intensity of A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"; normal splitting of S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"; no radiation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1ffa5c",
"class":"cell txt l",
"children":[
"May be present in conditions with increased flow (e.g., pregnancy, fever, anemia, hyperthyroidism)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c5569d",
"class":"cell txt l",
"children":[
"Hypertrophic obstructive cardiomyopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9f22e9",
"class":"cell txt l",
"children":[
"Systolic; crescendo-decrescendo"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b8459",
"class":"cell txt l",
"children":[
"LLSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"01bcd0",
"class":"cell txt l",
"children":[
"Enlarged, hyperdynamic apical impulse; bifid carotid impulse with delay; increased intensity during Valsalva maneuver or with squatting to standing"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e03ccf",
"class":"cell txt l",
"children":[
"Murmur may not be present in nonobstructive hypertrophic cardiomyopathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-11 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"87503e",
"class":"cell txt l",
"children":[
"Atrial septal defect"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9f22e9",
"class":"cell txt l",
"children":[
"Systolic; crescendo-decrescendo"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c7d4fe",
"class":"cell txt l",
"children":[
"RUSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e1257a",
"class":"cell txt l",
"children":[
"Fixed split S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"; right ventricular heave; rarely, tricuspid inflow murmur"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ec7659",
"class":"cell txt l",
"children":[
"May be associated with pulmonary hypertension with increased intensity of P",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
", pulmonary valve regurgitation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-12 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c26675",
"class":"cell txt l",
"children":[
"Ventricular septal defect"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd2ed7",
"class":"cell txt l",
"children":[
"Holosystolic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b8459",
"class":"cell txt l",
"children":[
"LLSB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b3188c",
"class":"cell txt l",
"children":[
"Palpable thrill; murmur increases with handgrip maneuver"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d8caf4",
"class":"cell txt l",
"children":[
"Murmur intensity and duration decrease as pulmonary hypertension develops (Eisenmenger syndrome)"
]
},
" ",
{
"type":"p",
"hlId":"57f612",
"class":"cell txt l",
"children":[
"Cyanosis if Eisenmenger syndrome develops"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" = aortic component of S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"; LLSB = left lower sternal border; LUSB = left upper sternal border; P",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" = pulmonic component of S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"; RLSB = right lower sternal border; RUSB = right upper sternal border."
]
]
},
"mk19_b_cv_t22":{
"id":"mk19_b_cv_t22",
"number":22,
"bookId":"cv",
"title":{
"__html":"Stages of Progression of Valvular Heart Disease"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"40804f",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 22. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_cv_t22"
}
]
},
"Stages of Progression of Valvular Heart Disease"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64c6da",
"class":"col hd l",
"children":[
"Stage"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b890b",
"class":"col hd l",
"children":[
"Definition"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b5a7ad",
"class":"col hd l",
"children":[
"Description"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7fc562",
"class":"cell txt l",
"children":[
"A"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1356c7",
"class":"cell txt l",
"children":[
"At risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f394e9",
"class":"cell txt l",
"children":[
"Patients with risk factors for development of VHD"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9d5ed6",
"class":"cell txt l",
"children":[
"B"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9712e7",
"class":"cell txt l",
"children":[
"Progressive"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0d0ca2",
"class":"cell txt l",
"children":[
"Patients with progressive VHD (mild to moderate severity and asymptomatic)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0d61f8",
"class":"cell txt l",
"children":[
"C"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"828afb",
"class":"cell txt l",
"children":[
"Asymptomatic severe"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26d3da",
"class":"cell txt l",
"children":[
"Asymptomatic patients who have the criteria for severe VHD:"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"223070",
"class":"cell txt li",
"children":[
"C1: Asymptomatic patients with severe VHD in whom the left or right ventricle remains compensated"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2611cc",
"class":"cell txt li",
"children":[
"C2: Asymptomatic patients with severe VHD, with decompensation of the left or right ventricle"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f623e7",
"class":"cell txt l",
"children":[
"D"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d7be1c",
"class":"cell txt l",
"children":[
"Symptomatic severe"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"52a132",
"class":"cell txt l",
"children":[
"Patients who have developed symptoms as a result of VHD"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"VHD = valvular heart disease."
],
[
"Reproduced with permission from Otto CM, Nishimura RA, Bonow RO, et al; Writing Committee Members. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77:e25-e197. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33342586",
"target":"_blank"
},
"children":[
"PMID: 33342586"
]
},
" doi:10.1016/j.jacc.2020.11.018. ©2021 American College of Cardiology Foundation and the American Heart Association, Inc."
]
]
},
"mk19_b_cv_t23":{
"id":"mk19_b_cv_t23",
"number":23,
"bookId":"cv",
"title":{
"__html":"Serial Evaluation of Asymptomatic Patients with Left-Sided Valvular Conditions"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"e88117",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 23. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_cv_t23"
}
]
},
"Serial Evaluation of Asymptomatic Patients with Left-Sided Valvular Conditions"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3cc259",
"class":"col hd l",
"children":[
"Factors Considered"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d6d4c8",
"class":"col hd l",
"children":[
"Lesion Severity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"24a638",
"class":"col hd l",
"children":[
"Frequency of Evaluation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"5be17a",
"class":"col hd l",
"children":[
"Aortic Stenosis"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c27f1f",
"class":"cell txt l",
"children":[
"Stenosis severity; rate of progression; LV systolic function; ascending aorta dilation if associated with bicuspid aortic valve"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3edb5a",
"class":"cell txt l",
"children":[
"At risk (V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"max"
]
},
" <2 m/s)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"418fd4",
"class":"cell txt l",
"children":[
"Mild (V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"max"
]
},
" 2.0-2.9 m/s or mean gradient <20 mm Hg)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8d97a5",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo every 3-5 y"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6abb1",
"class":"cell txt l",
"children":[
"Moderate (V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"max"
]
},
" 3.0-3.9 m/s or mean gradient 20-39 mm Hg)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd504b",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo every 1-2 y"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"443257",
"class":"cell txt l",
"children":[
"Severe (V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"max"
]
},
" ≥4 m/s or mean gradient ≥40 mm Hg, AVA typically ≤1.0 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
")"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd6574",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo every 6-12 mo"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dc5e3c",
"class":"cell txt l",
"children":[
"Very severe (V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"max"
]
},
" ≥5 m/s or mean gradient ≥60 mm Hg)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd6574",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo every 6-12 mo"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"035ea8",
"class":"col hd l",
"children":[
"Aortic Regurgitation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7db821",
"class":"cell txt l",
"children":[
"Regurgitation severity; rate of progression; LV ejection fraction; LV chamber size; ascending aorta dilation if bicuspid aortic valve"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a94e2f",
"class":"cell txt l",
"children":[
"Mild (VC <0.3 cm, ERO <0.10 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
", RV <30 mL/beat, RF <30%); normal EF"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8d97a5",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo every 3-5 y"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5e5909",
"class":"cell txt l",
"children":[
"Moderate (VC 0.3-0.6 cm, ERO 0.10-0.29 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
", RV 30-59 mL/beat, RF 30%-49%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd504b",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo every 1-2 y"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7b1cb8",
"class":"cell txt l",
"children":[
"Severe (VC >0.6 cm, ERO ≥0.3 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
", RV ≥60 mL/beat, RF ≥50%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b91ccb",
"class":"cell txt li",
"children":[
"EF ≥55%; LVESD ≤50 mm"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"859b49",
"class":"cell txt l",
"children":[
"Clinical evaluation every 6-12 mo; echo every 6-12 mo, more frequently for dilating LV"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9c67e8",
"class":"cell txt li",
"children":[
"EF <55%; LVESD >50 mm"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"859b49",
"class":"cell txt l",
"children":[
"Clinical evaluation every 6-12 mo; echo every 6-12 mo, more frequently for dilating LV"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"3c8aab",
"class":"col hd l",
"children":[
"Mitral Stenosis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"740157",
"class":"cell txt l",
"children":[
"Stenosis severity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d773f3",
"class":"cell txt l",
"children":[
"Mild and moderate (MVA >1.5 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
", diastolic pressure half-time <150 ms)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8d97a5",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo every 3-5 y"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ee8b6e",
"class":"cell txt l",
"children":[
"Severe (MVA ≤1.5 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
", diastolic pressure half-time ≥150 ms or ≥220 ms with very severe stenosis, PASP >50 mm Hg)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2c16a3",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo every 1-2 y for MVA 1.0-1.5 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
", every year for MVA <1.0 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"c3e60a",
"class":"col hd l",
"children":[
"Mitral Regurgitation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3e1578",
"class":"cell txt l",
"children":[
"Regurgitation severity; rate of progression; EF; LV chamber size"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4d3d09",
"class":"cell txt l",
"children":[
"At risk (VC <0.3 cm)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"62eaec",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo only if symptomatic"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f17e92",
"class":"cell txt l",
"children":[
"Mild and moderate (VC <0.7 cm, ERO <0.40 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
", RV <60 mL/beat, RF <50%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c111c7",
"class":"cell txt l",
"children":[
"Clinical evaluation yearly; echo every 3-5 y for mild severity, every 1-2 y for moderate severity"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b42253",
"class":"cell txt l",
"children":[
"Severe (VC ≥0.7 cm, ERO ≥0.4 cm",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
", RV ≥60 mL/beat, RF ≥50%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"859b49",
"class":"cell txt l",
"children":[
"Clinical evaluation every 6-12 mo; echo every 6-12 mo, more frequently for dilating LV"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"AVA = aortic valve area; echo = echocardiography; EF = ejection fraction; ERO = effective regurgitant orifice; LV = left ventricular; LVESD = left ventricular end-systolic dimension; MVA = mitral valve area; PASP = pulmonary artery systolic pressure; RF = regurgitant fraction; RV = regurgitant volume; VC = vena contracta width; V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"max"
]
},
" = maximum aortic jet velocity."
],
[
"Recommendations based on Otto CM, Nishimura RA, Bonow RO, et al; Writing Committee Members. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77:e25-e197. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33342586",
"target":"_blank"
},
"children":[
"PMID: 33342586"
]
},
" doi:10.1016/j.jacc.2020.11.018"
]
]
},
"mk19_b_cv_t24":{
"id":"mk19_b_cv_t24",
"number":24,
"bookId":"cv",
"title":{
"__html":"Major and Minor Criteria Used in the Modified Duke Criteria"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"80cdbd",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 24. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_cv_t24"
}
]
},
"Major and Minor Criteria Used in the Modified Duke Criteria"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c171ea",
"class":"col hd l",
"children":[
"Major Criteria"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fce1ae",
"class":"cell txt l",
"children":[
"Blood culture positive for infective endocarditis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"78d0bf",
"class":"cell txt li",
"children":[
"Typical microorganisms consistent with infective endocarditis from two separate blood cultures: Viridans streptococci, ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Streptococcus bovis"
]
},
", HACEK group (",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Haemophilus"
]
},
" spp., ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Actinobacillus actinomycetemcomitans"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Cardiobacterium hominis"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Eikenella"
]
},
" spp., and ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Kingella kingae"
]
},
"), ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Staphylococcus aureus"
]
},
"; or community-acquired enterococci, in the absence of a primary focus; or"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b8afc4",
"class":"cell txt li",
"children":[
"Microorganisms consistent with infective endocarditis from persistently positive blood cultures, defined as follows:"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6b90b6",
"class":"cell txt lii",
"children":[
"At least two positive cultures of blood samples drawn 12 h apart; or"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5a9870",
"class":"cell txt lii",
"children":[
"All of three or a majority of at least four separate cultures of blood (with first and last samples drawn at least 1 h apart)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"75d246",
"class":"cell txt li",
"children":[
"Single blood culture positive for ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Coxiella burnetii"
]
},
" or antiphase I IgG antibody titer >1:800"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"75b499",
"class":"cell txt l",
"children":[
"Evidence of endocardial involvement"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bad84c",
"class":"cell txt li",
"children":[
"Echocardiogram positive for infective endocarditis (TEE recommended in patients with prosthetic valves, rated at least “possible infective endocarditis” by clinical criteria, or complicated infective endocarditis [paravalvular abscess]; TTE as first test in other patients), defined as follows:"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1483c0",
"class":"cell txt lii",
"children":[
"Oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets, or on implanted material in the absence of an alternative anatomic explanation; or"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e3a388",
"class":"cell txt lii",
"children":[
"Abscess; or"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"50fe81",
"class":"cell txt lii",
"children":[
"New partial dehiscence of prosthetic valve"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f7e36a",
"class":"cell txt li",
"children":[
"New valvular regurgitation (worsening or changing of pre-existing murmur not sufficient)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8a5855",
"class":"col hd l",
"children":[
"Minor Criteria"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1d100c",
"class":"cell txt l",
"children":[
"Predisposition, predisposing heart condition, or injection drug use"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2acaa8",
"class":"cell txt l",
"children":[
"Fever (temperature >38°C [100.4°F])"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1bed43",
"class":"cell txt l",
"children":[
"Vascular phenomena: major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, and Janeway lesions"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ebc756",
"class":"cell txt l",
"children":[
"Immunologic phenomena: glomerulonephritis, Osler nodes, Roth spots, and rheumatoid factor"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1569f0",
"class":"cell txt l",
"children":[
"Microbiologic evidence: positive blood culture but does not meet a major criterion as noted above",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" or serologic evidence of active infection with organism consistent with infective endocarditis"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"TEE = transesophageal echocardiography; TTE = transthoracic echocardiography."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Excludes single culture positive for coagulase-negative staphylococci and organisms that do not cause endocarditis."
],
[
"Reproduced with permission from Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-8. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/10770721",
"target":"_blank"
},
"children":[
"PMID: 10770721"
]
},
" doi:10.1086/313753 ©2000 Oxford University Press."
]
]
},
"mk19_b_cv_t25":{
"id":"mk19_b_cv_t25",
"number":25,
"bookId":"cv",
"title":{
"__html":"Empiric Antibiotic Therapy for Critically Ill Patients with Acute Endocarditis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"52808d",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 25. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_cv_t25"
}
]
},
"Empiric Antibiotic Therapy for Critically Ill Patients with Acute Endocarditis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e2941",
"class":"col hd l",
"children":[
"Condition"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"621c6f",
"class":"col hd l",
"children":[
"European Society of Cardiology (2015)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b23c77",
"class":"col hd l",
"children":[
"American Heart Association (2005)"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3a2681",
"class":"cell txt l",
"children":[
"Community-acquired native valve endocarditis or late prosthetic valve endocarditis (≥12 months after surgery)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8c35d9",
"class":"cell txt l",
"children":[
"Ampicillin"
]
},
" ",
{
"type":"p",
"hlId":"23a58b",
"class":"cell txt l",
"children":[
"with"
]
},
" ",
{
"type":"p",
"hlId":"eb9545",
"class":"cell txt l",
"children":[
"(Flu)cloxacillin or oxacillin"
]
},
" ",
{
"type":"p",
"hlId":"23a58b",
"class":"cell txt l",
"children":[
"with"
]
},
" ",
{
"type":"p",
"hlId":"5e7597",
"class":"cell txt l",
"children":[
"Gentamicin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21a4dc",
"class":"cell txt l",
"children":[
"Vancomycin"
]
},
" ",
{
"type":"p",
"hlId":"23a58b",
"class":"cell txt l",
"children":[
"with"
]
},
" ",
{
"type":"p",
"hlId":"9dffeb",
"class":"cell txt l",
"children":[
"Cefepime or ceftriaxone (for prosthetic valve endocarditis)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8fa0d4",
"class":"cell txt l",
"children":[
"Community-acquired native valve endocarditis or late prosthetic valve endocarditis (≥12 months after surgery), penicillin-allergic patient"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21a4dc",
"class":"cell txt l",
"children":[
"Vancomycin"
]
},
" ",
{
"type":"p",
"hlId":"23a58b",
"class":"cell txt l",
"children":[
"with"
]
},
" ",
{
"type":"p",
"hlId":"5e7597",
"class":"cell txt l",
"children":[
"Gentamicin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ea4b1d",
"class":"cell txt l",
"children":[
"No specific regimen provided"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f2a6b5",
"class":"cell txt l",
"children":[
"Early prosthetic valve endocarditis (<12 months after surgery) or health care–associated endocarditis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21a4dc",
"class":"cell txt l",
"children":[
"Vancomycin"
]
},
" ",
{
"type":"p",
"hlId":"23a58b",
"class":"cell txt l",
"children":[
"with"
]
},
" ",
{
"type":"p",
"hlId":"5e7597",
"class":"cell txt l",
"children":[
"Gentamicin"
]
},
" ",
{
"type":"p",
"hlId":"23a58b",
"class":"cell txt l",
"children":[
"with"
]
},
" ",
{
"type":"p",
"hlId":"1760c4",
"class":"cell txt l",
"children":[
"Rifampin",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21a4dc",
"class":"cell txt l",
"children":[
"Vancomycin"
]
},
" ",
{
"type":"p",
"hlId":"23a58b",
"class":"cell txt l",
"children":[
"with"
]
},
" ",
{
"type":"p",
"hlId":"5e7597",
"class":"cell txt l",
"children":[
"Gentamicin"
]
},
" ",
{
"type":"p",
"hlId":"23a58b",
"class":"cell txt l",
"children":[
"with"
]
},
" ",
{
"type":"p",
"hlId":"1760c4",
"class":"cell txt l",
"children":[
"Rifampin",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"23a58b",
"class":"cell txt l",
"children":[
"with"
]
},
" ",
{
"type":"p",
"hlId":"deaa4d",
"class":"cell txt l",
"children":[
"Cefepime"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Some experts recommend delaying the start of rifampin for 3-5 days in an attempt to prevent the emergence of resistance to rifampin."
],
[
"Information from Habib G, Lancellotti P, Antunes MJ, et al; ESC Scientific Document Group. 2015 ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075-3128. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26320109",
"target":"_blank"
},
"children":[
"PMID: 26320109"
]
},
" doi:10.1093/eurheartj/ehv319 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Baddour LM, Wilson WR, Bayer AS, et al; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394-434. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/15956145",
"target":"_blank"
},
"children":[
"PMID: 15956145"
]
},
" doi:10.1161/CIRCULATIONAHA.105.165564"
]
]
},
"mk19_b_cv_t26":{
"id":"mk19_b_cv_t26",
"number":26,
"bookId":"cv",
"title":{
"__html":"Prophylactic Infective Endocarditis Regimens for Adults at Highest Risk of an Adverse Outcome Before a Dental Procedure"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"12bbde",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 26. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_cv_t26"
}
]
},
"Prophylactic Infective Endocarditis Regimens for Adults at Highest Risk of an Adverse Outcome Before a Dental Procedure"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e8d9fe",
"class":"col hd l",
"children":[
"Situation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"744605",
"class":"col hd l",
"children":[
"Agent"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"051628",
"class":"col hd l",
"children":[
"Dosage",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1dfec3",
"class":"cell txt l",
"children":[
"Oral"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25a01f",
"class":"cell txt l",
"children":[
"Amoxicillin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"848490",
"class":"cell txt l",
"children":[
"2 g"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e61258",
"class":"cell txt l",
"children":[
"Unable to take oral medication"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8c35d9",
"class":"cell txt l",
"children":[
"Ampicillin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0d989d",
"class":"cell txt l",
"children":[
"2 g IM or IV"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8e0c4e",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7b86c6",
"class":"cell txt l",
"children":[
"Cefazolin or ceftriaxone"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c755e9",
"class":"cell txt l",
"children":[
"1 g IM or IV"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6b692",
"class":"cell txt l",
"children":[
"Allergic to penicillin or ampicillin – oral"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3304c4",
"class":"cell txt l",
"children":[
"Cephalexin",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b,c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"848490",
"class":"cell txt l",
"children":[
"2 g"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8e0c4e",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f52605",
"class":"cell txt l",
"children":[
"Clindamycin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fd5c64",
"class":"cell txt l",
"children":[
"600 mg"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8e0c4e",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8532a9",
"class":"cell txt l",
"children":[
"Azithromycin or clarithromycin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5ef028",
"class":"cell txt l",
"children":[
"500 mg"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8e0c4e",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e923ca",
"class":"cell txt l",
"children":[
"Doxycycline"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c04dcd",
"class":"cell txt l",
"children":[
"100 mg"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"747021",
"class":"cell txt l",
"children":[
"Allergic to penicillin or ampicillin and unable to take oral medication"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7b86c6",
"class":"cell txt l",
"children":[
"Cefazolin or ceftriaxone"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c755e9",
"class":"cell txt l",
"children":[
"1 g IM or IV"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"IM = intramuscular; IV = intravenous."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Regimen consists of a single dose 30 to 60 minutes before the dental procedure, or, if inadvertently not administered, drug may be given up to 2 hours after the procedure."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Or other first- or second-generation oral cephalosporin in equivalent adult dosage."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Cephalosporins should not be used in an individual with a history of anaphylaxis, angioedema, or urticaria with penicillins or ampicillin."
],
[
"Information from Wilson WR, Gewitz M, Lockhart PB, et al; American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and the Council on Quality of Care and Outcomes Research. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation. 2021;e963-e978. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33853363",
"target":"_blank"
},
"children":[
"PMID: 33853363"
]
},
". doi:10.1161/CIR.0000000000000969"
]
]
}
}
}